Despite similarities in microsatellite instability (MSI) between colon and endometrial cancer, there are many clinically important organ-specific features. The molecular differences between these 2 MSI cancers are underexplored because the usual differentially expressed gene analysis yields too many noncancer-specific normally expressed genes. We aimed to identify cancer-specific genes in MSI colorectal adenocarcinoma (CRC) and MSI endometrial carcinoma (ECs) using a modified partial least squares discriminant analysis. We obtained a list of cancer-specific genes in MSI CRC and EC by taking the intersection of the genes obtained from tumor samples and normal samples. Specifically, we obtained publically available 1319 RNA sequencing data consisting of MSI CRCs, MSI ECs, normal colon including the rectum, and normal endometrium from The Cancer Genome Atlas and genome-tissue expression sites. To reduce gene-centric dimensions, we retained only 3924 genes from the original data by performing the usual differentially expressed gene screening for tumor samples using DESeq2. The usual partial least squares discriminant analysis was performed for tumor samples, producing 625 genes, whereas for normal samples, projection vectors with zero covariance were sampled, their weights were square-summed, and genes with sufficiently high values were selected. Gene ontology (GO) term enrichment, protein–protein interaction, and survival analyses were performed for functional and clinical validation. We identified 30 cancer-specific normal-invariant genes, including Zic family members (ZIC1, ZIC4, and ZIC5), DPPA2, PRSS56, ELF5, and FGF18, most of which were cancer-associated genes. Although no statistically significant GO terms were identified in the GO term enrichment analysis, cell differentiation was observed as potentially significant. In the protein–protein interaction analysis, 17 of the 30 genes had at least one connection, and when first-degree neighbors were added to the network, many cancer-related pathways, including MAPK, Ras, and PI3K-Akt, were enriched. In the survival analysis, 16 genes showed statistically significant differences between the lower and higher expression groups (3 in CRCs and 15 ECs). We developed a novel approach for selecting cancer-specific normal-invariant genes from relevant gene expression data. Although we believe that tissue-specific reactivation of embryonic genes might explain the cancer-specific differences of MSI CRC and EC, further studies are needed for validation.